EUVIMEDEUVIMED entdecken
Crossref

NOC4L: An Emerging Dual-Action Target for Cancer Prognosis and Immunotherapy

Hai Bai, Wanqing Xu, Guozheng Wei, Yue Cao, Mingming Wang

Applied Biochemistry and Biotechnology · 2026-12 · 198 (12) · 10685-10710

DOI: 10.1007/s12010-026-05931-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Biochemistry and Biotechnology, online erschienen am 23.09.2026. Verfasst von Hai Bai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Applied Biotechnology, College of Agronomy and Life Science, Shanxi Datong University, Datong, Shanxi province, 037009, PR China. Hauptthemen laut MEDLINE: Immunotherapy, Neoplasms, Biomarkers, Tumor, Nuclear Proteins. Die Arbeit nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyNeoplasmsBiomarkers, TumorNuclear ProteinsHumansPrognosisGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

BiomarkersImmune MicroenvironmentImmunotherapyNOC4LPrognostic Marker

Substanzen

Biomarkers, TumorNuclear Proteins

Autor:innen und Institutionen

  • Institute of Applied Biotechnology, College of Agronomy and Life Science, Shanxi Datong University, Datong, Shanxi province, 037009, PR China.
  • Department of Physiology, School of Basic Medicine and Life Sciences, Xuzhou Medical University, Xuzhou, Jiangsu Province, 221004, PR China.
  • Xuzhou Key Laboratory of Physiological Function and Injury, Xuzhou Medical University, Xuzhou, Jiangsu Province, 221004, P.R. China.
  • Department of Physiology, School of Basic Medicine and Life Sciences, Xuzhou Medical University, Xuzhou, Jiangsu Province, 221004, PR China. wmm@xzhmu.edu.cn.
  • Xuzhou Key Laboratory of Physiological Function and Injury, Xuzhou Medical University, Xuzhou, Jiangsu Province, 221004, P.R. China. wmm@xzhmu.edu.cn.
  • National Experimental Teaching Demonstration Center for Basic Medicine, Xuzhou Medical University, Xuzhou, Jiangsu Province, 221004, P.R. China. wmm@xzhmu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Bai, H., Xu, W., Wei, G., Cao, Y., & Wang, M. (2026). NOC4L: An Emerging Dual-Action Target for Cancer Prognosis and Immunotherapy. Applied Biochemistry and Biotechnology, 198(12), 10685-10710. https://doi.org/10.1007/s12010-026-05931-3

Vancouver

Bai H, Xu W, Wei G, Cao Y, Wang M. NOC4L: An Emerging Dual-Action Target for Cancer Prognosis and Immunotherapy. Applied Biochemistry and Biotechnology. 2026;198(12):10685-10710. doi:10.1007/s12010-026-05931-3

BibTeX
@article{Bai2026,
  author = {Bai, Hai and Xu, Wanqing and Wei, Guozheng and Cao, Yue and Wang, Mingming},
  title = {NOC4L: An Emerging Dual-Action Target for Cancer Prognosis and Immunotherapy},
  journal = {Applied Biochemistry and Biotechnology},
  year = {2026},
  volume = {198},
  number = {12},
  pages = {10685--10710},
  doi = {10.1007/s12010-026-05931-3}
}
Kostenlos starten →